MAGE-A9 is one of the more frequently expressed CTAs in human tumors, including melanomas, head and neck squamous cell carcinomas, non-small-cell lung carcinomas, multiple myelomas, and hepatocellular carcinomas. This evidence concerns the gene MAGEA9 and hepatocellular carcinoma.